Risk estimation - An overview: Disease risk estimation based upon animal bioassays

Drug Metabolism Reviews

Volumn 28, Issue 1-2, 1996, Pages 9-27

  Gaylor, David W ^a,b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b Division of Biometry   (United States)

Author keywords

bioassay protocols; cancer; exposure conditions; non cancer end points; risk estimation

Indexed keywords

BIOASSAY; CANCER RISK; CONFERENCE PAPER; NONHUMAN; RISK ASSESSMENT; THEORETICAL STUDY;

EID: 0029892555     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.3109/03602539608993989     Document Type: Conference Paper

References (67)

1. Abdo, K. M., Haseman, J. K., Morris, R., Hailey, R. J., and Kari, F. W. The effect of feed restriction on the chronic toxicity and carcinogenicity of two coded chemicals administered by dosed feed to F344 rats (abstract), Conference on Dietary Restriction, ILSI, Washington, DC, 1994.
2. Ahn, H., and Kodell, R. L. Estimation and testing of tumor incidence rates in experiments lacking cause-of-death data, Biometrical J., 37, 745-763 (1995).
3. Allen, B. C., Crump, K. S., and Shipp, A. M. Correlation between carcinogenic potency of chemicals in animals and humans, Risk Analysis, 8, 531-544 (1988).
4. Barnes, D. G., and Dourson, M. Reference dose (RfD): Description and use in health risk assessments, Regulatory Toxicol. Pharmacol., 8, 471-486 (1988).
5. Brown, C. C., and Chu, K. C. Additive and multiplicative models and multistage carcinogenesis theory, Risk Analysis, 9, 99-105 (1989).
6. Catalano, P. J., Ryan, L., and Scharfstein, D. O. Modeling fetal death and malformation in developmental toxicity. Risk Analysis, 14, 629-637 (1994).
7. Catalano, P. J., Scharfstein, D. O., Ryan, L. M., Kimmel, C. A., and Kimmel, G. L. Statistical model for fetal death, fetal weight, and malformation in developmental toxicity studies, Teratology, 47, 281-290 (1993).
8. Chen, J. J. A malformation incidence dose-response model incorporating fetal weight and/or litter size as covariates, Risk Analysis, 13, 559-564 (1993).
9. Chen, J. J., Gaylor, D. W., and Kodell, R. L. Estimation of the joint risk from multiple-compound exposure based on single-compound experiments, Risk Analysis, 10, 285-290 (1990).
10. Chen, J. J., and Kodell, R. L. Quantitative risk assessment for teratological effects, J. Am. Statistical Assoc., 84, 966-971 (1989).
11. Chen, J. J., Kodell, R. L., and Gaylor, D. W. Using the biological two-stage model to assess risk from short-term exposures, Risk Analysis, 8, 223-230 (1988).
12. Chen, J. J. Kodell, R. L., Howe, R. B., and Gaylor, D. W. Analysis of trinomial responses from reproductive and developmental toxicity experiments, Biometrics, 47, 1049-1058 (1991).
13. Cohen, S. M., and Ellwein, L. B. Cell proliferation in carcinogenesis, Science, 249, 1007-1011 (1990).
14. Crump, K. S. A new method for determining allowable daily intakes, Fundam. Appl. ToxicoL, 4, 854-871 (1984).
15. Crump, K. S., Hoel, D. G., Langley, C. H., and Peto, R. Fundamental carcinogenic processes and their implications for low dose risk assessment, Cancer Res., 36, 2973-2979 (1976).
16. Crump, K. S., and Howe, R. B. The multistage model with a time-dependent dose pattern: Applications to carcinogen risk assessment, Risk Analysis, 4, 163-179 (1984).
17. Dinse, G. E. A comparison of tumour incidence analyses applicable in single-sacrifice animal experiments, Stat. Med., 13, 689-708 (1994).
18. Farmer, J. H., Kodell, R. L., and Gaylor, D. W. Estimation and extrapolation of tumor probabilities from a mouse bioassay with survival/sacrifice components. Risk Analysis, 2, 27-34 (1982).
19. Fung, K. Y., Krewski, D., Rao, J. N. K., and Scott, A. J. Tests for trend in developmental toxicity experiments with correlated binary data, Risk Analysis, 14, 639-648 (1994).
20. Gaylor, D. W. Incidence of developmental defects at the no observed adverse effect level (NOAEL), Regulatory Toxicol. Pharmacol., 15, 151-160 (1992a).
21. Gaylor, D. W. Relationship between the shape of dose-response curves and background tumor rates, Regulatory Toxicol. Pharmacol., 16, 2-9 (1992b).
22. Gaylor, D. W., and Chen, J. J. Dose-response models for developmental malformations. Teratology, 47, 291-297 (1993).
23. Gaylor, D. W., Chen, J. J., and Sheehan, D. M. Uncertainty in cancer risk estimates. Risk Analysis, 13, 149-154 (1993).
24. Gaylor, D. W., and Gold, L. S. Estimation of potential carcinogenic potency based on the 90-day maximum tolerated dose, Regulatory Toxicol. Pharmacol., 22, 57-63 (1995).
25. Gaylor, D. W., and Kodell, R. L. Linear interpolation algorithm for low dose risk assessment of toxic substances, J. Environ. Pathol. Toxicol., 4, 305-315 (1980).
26. Gaylor, D. W., Kodell, R. L., Chen, J. J., Springer, J. A., Lorentzen, R. J., and Scheuplein, R. J. Point estimates of cancer risk at low doses. Risk Analysis, 14, 843-850 (1994).
27. Gaylor, D. W., and Slikker, W., Jr. Risk assessment for neurotoxic effects. NeuroToxicology, 11, 211-218 (1990).
28. Gaylor, D. W., and Slikker, W., Jr. Modeling for risk assessment of neurotoxic effects, Risk Analysis, 14, 333-338 (1994).
29. Gibbs, H. J., and Chen, C. W. Multistage model interpretation of additive and multiplicative carcinogenic effects, Risk Analysis, 6, 167-170 (1986).
30. Gold, L. S., Bernstein, L., MaGaw, R., and Slone, T. Interspecies extrapolation in carcinogenesis: Prediction between rats and mice, Environ. Health Perpsect., 81, 211-219 (1989).
31. Gold, L. S., Sawyer, C. B., MaGaw, R., Buckman, G. M., de Veciana, M., Levinson, R., Hooper, N. K., Havendor, W. R., Bernstein, L., Peto, R., Pike, M. C., and Ames, B. N. A carcinogenic potency database of the standardized results of animal bioassays, Environ. Health Perspect., 58, 9-319 (1984).
32. Gold, L. S., Slone, T. H., and Bernstein, L. Summary of carcinogenic potency and positivity for 492 rodent carcinogens in the carcinogenic potency database, Environ. Health Perspect., 79, 259-272 (1989).
33. Gold, L. S., Wright, C., Bernstein, L., and de Veciana, M. Reproducibility of results in "near-replicate" carcinogenesis bioassays, J. Natl. Cancer Instit., 78, 1149-1158 (1987).
34. Hart, R. W., and Turturro, A. Dietary restriction: An update. In Dietary Restriction: Implications for the Design and Interpretation of Toxicity and Carcinogenicity Studies (R. Hart, D. Neumann, and R. Robertson, eds.), ILSI Press, Washington, DC, 1994, pp. 1-12.
35. Haseman, J. K., and Huff, J. E. Species correlation in long-term carcinogenicity studies, Cancer Lett., 37, 125-132 (1987).
36. Haseman, J. K., and Rao, G. N. Effects of corn oil, time-related changes, and interlaboratory variability in tumor occurrence in control Fischer 344 (F344/N) rats, Toxicologic Pathol., 20, 52-60 (1992).
37. Hoel, D. G. Incorporation of background in dose-response models, Fed. Proc., 39, 73-75 (1980).
38. Kari, F. W., and Abdo, K. M. The effect of feed restriction on the sensitivity of the NTP carcinogenicity bioassay (abstract), Conference on Dietary Restriction, ILSI, Washington, DC, 1994.
39. Kari, F. W., Haseman, J. K., and Morris, R., Hailey, R., and Abdo, K. M. The effects of feed restriction on the carcinogenicity of two coded chemicals in NTP gavage studies (abstract), Conference on Dietary Restriction, ILSI, Washington, DC, 1994.
40. Kodell, R. L., and Gaylor, D. W. On the additive and multiplicative models of relative risk, Biometric. J., 31, 359-370 (1989).
41. Kodell, R. L., Gaylor, D. W., and Chen, J. J. Using average lifetime dose rate for intermittent exposures to carcinogens, Risk Analysis, 7, 339-345 (1987).
42. Kodell, R. L., Haskin, M. G., Shaw, G. W., and Gaylor, D. W. CHRONIC: A SAS procedure for statistical analysis of carcinogenesis studies, J. Stat. Comput. Simul., 16, 287-310 (1983).
43. Kodell, R. L., Howe, R. B., Chen, J. J., and Gaylor, D. W. Mathematical modelling of reproductive and developmental toxic effects for quantitative risk assessment. Risk Analysis, 11, 583-590 (1991).
44. Kodell, R. L., Krewski, D., and Zielinski, J. M. Additive and multiplicative relative risk in the two-stage clonal expansion model of carcinogenesis, Risk Analysis, 11, 483-490 (1991b).
45. Kopp-Schneider, A., Portier, C. J., and Sherman, C. D. The exact formula for tumor incidence in the two-stage model, Risk Analysis, 14, 1079-1080 (1994).
46. Krewski, D., Gaylor, D. W., and Lutz, W. K. Additivity to background and linear extrapolation. In Low-Dose Extrapolation of Cancer Risks: Issues and Perspectives (S. Olin, W. Farland, C. Park, L. Rhomberg, R. Scheuplein, T. Starr, and J. Wilson, eds.), ILSI Press, Washington, DC, 1995, pp. 105-121.
47. Krewski, D., and Zhu, Y. Applications of multinomial dose-response models in developmental toxicity risk assessment, Risk Analysis, 14, 613-627 (1994).
48. Lai, D. Y. Perspective on alternative carcinogenicity testing design: Possible use of reduced protocols, mechanistic data and predictive techniques. Environ. Carcinogen. Ecotoxicol. Rev., C10, 121-140 (1992).
49. Lefkopoulou, M., and Ryan, L. Global tests for multiple binary outcomes, Biometrics, 49, 975-988 (1993).
50. Lutz, W. K. Dose-response relationship and low dose extrapolation in chemical carcinogenesis, Carcinogenesis, 11, 1243-1247 (1990).
51. Moolgavkar, S. H., and Knudson, A. G. Mutation and cancer: A model for human carcinogenesis, J. Natl. Cancer Inst., 66, 1037-1052 (1981).
52. Moolgavkar, S. H., and Venzon, D. J. Two-event models for carcinogenesis: Incidence curves for childhood and adult tumors, Math. Biosci., 47, 55-77 (1979).
53. National Research Council. Complex Mixtures: Methods for In Vivo Toxicity Testing, National Academy Press, Washington, DC, 1988.
54. National Research Council. Drinking Water and Health, Vol. 9: Selected Issues in Risk Assessment, National Academy Press, Washington, DC, 1989.
55. National Research Council. Issues in Risk Assessment. National Academy Press. Washington, DC, 1993, pp. 190-196.
56. Peto, R. Carcinogenic effects of chronic exposure to very low levels of toxic substances, Environ. Health Perspect. 22, 155-161 (1978).
57. Peto, R., Pike, M. C., Day, N. E., Gray, R. G., Lee, P. N., Parish, S., Peto, J., Richards, S., and Wahrendorf, J. Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments, IARC Monographs, Suppl. 2, International Agency for Research on Cancer, Lyon, France, 1980.
58. Rao, J. N. K., and Scott, A. J. A simple method for the analysis of clustered binary data, Biometrics, 48, 577-585 (1992).
59. Rulis, A. M. De minimis and the threshold of regulation, in Food Protection Technology (C. W. Felix, ed.), Lewis Publ., Chelsea, MI, 1986, pp. 29-37.
60. Rulis, A. M. Establishing a threshold of regulation, in Risk Assessment in Setting National Priorities (J. J. Bonin and D. E. Stevenson, eds.), Plenum, New York, 1989, pp. 271-278.
61. Rulis, A. M. Threshold of regulation: Options for handling minimal risk situations, in Food Safety Assessment, Am. Chem. Soc. Symp. Ser. 484, 1992, pp. 132-139.
62. Thurman, J. D., Hailey, J. R., Turturro, A., and Gaylor, D. W. Spontaneous renal tubular carcinoma in Fischer-344 littermates, Vet. Pathol., 32, 419-422 (1995).
63. Turturro, A., Duffy, P. H., and Hart, R. W. Modulation for toxicity by diet and dietary macronutrient restriction, Mutat. Res., 295, 151-164 (1993).
64. 3/4/day, Fed. Reg., 57(109), 24152-24173 (1992).
65. U.S. Food and Drug Administration. Food additives: Threshold of regulation for substances used in food-contact articles, Fed. Reg. 55(195): 52719-52729 (1993).
66. Zeise, L., Wilson, R., and Crouch, E. Use of acute toxicity to estimate carcinogenic risk, Risk Analysis, 4, 187-199 (1984).
67. Zheng, Q. On the exact hazard and survival functions of the MVK stochastic carcinogenesis model, Risk Analysis, 14, 1081-1084 (1994).